Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL
9 Visualizzazioni
• 08/09/23
0
0
Incorporare
administrator
Iscritti
Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti